OTCMKTS:VICP Vicapsys Life Sciences (VICP) Stock Price, News & Analysis → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free VICP Stock Alerts $0.44 0.00 (0.00%) (As of 05/9/2024 ET) Add Compare Share Share Today's Range$0.44▼$0.4450-Day Range$0.44▼$2.2552-Week Range$0.44▼$3.00VolumeN/AAverage Volume414 shsMarket Capitalization$14.24 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsSEC FilingsStock AnalysisChartEarningsFinancialsSEC Filings Get Vicapsys Life Sciences alerts: Email Address Ad Priority GoldThe 2024 Gold Rush: Unleashing Market PotentialWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. About Vicapsys Life Sciences Stock (OTCMKTS:VICP)Vicapsys Life Sciences, Inc. focuses on the development and commercialization of VICAPSYN, a proprietary product. The company's product is applied to transplantation therapies and related stem-cell applications in the transplantation field. It also develops VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers. The company was formerly known as Phage Therapeutics International, Inc. and changed its name to Vicapsys Life Sciences, Inc. in September 2017. Vicapsys Life Sciences, Inc. was incorporated in 1997 and is based in Suwanee, Georgia.Read More VICP Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VICP Stock News HeadlinesApril 28, 2024 | usatoday.comBest term life insurance: Expert-rated in April 2024November 4, 2023 | morningstar.comAnavex Life Sciences Corp AVXLMay 9, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.August 9, 2023 | finance.yahoo.comVICP - Vicapsys Life Sciences, Inc.July 3, 2023 | msn.comViCapsys files for Nasdaq uplisting, $8M public offeringFebruary 19, 2023 | benzinga.comGlobal Life Science Tools Strategic Business Report 2023: Rapid Growth in Biopharma Industry and Rising Investments in R&D to Boost Market ProspectsSeptember 29, 2022 | finance.yahoo.comViCapsys Life Sciences Appoints Three New Board MembersApril 18, 2022 | finance.yahoo.comViCapsys Life Sciences Appoints Federico Pier as Permanent Chief Executive OfficerSee More Headlines Receive VICP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vicapsys Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorConstruction Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:VICP CUSIPN/A CIK1468639 Webvicapsys.com Phone(972) 891-8033FaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-990,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-598.80% Debt Debt-to-Equity RatioN/A Current Ratio0.13 Quick Ratio0.13 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.03) per share Price / Book-14.80Miscellaneous Outstanding Shares32,071,000Free Float30,153,000Market Cap$14.24 million OptionableNot Optionable Beta-5.62 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Federico Pier (Age 56)CEO, Executive Chairman & Interim President Comp: $120kMr. Jeffery Wright CPA (Age 41)CPA, Chief Financial Officer Comp: $90kDr. Mark C. Poznansky M.D.Ph.D., Chief Scientist Advisor & FounderKey CompetitorsInnoNASDAQ:INHDWilliams Industrial Services GroupOTCMKTS:WLMSIntelligent Living Application GroupNASDAQ:ILAGENGlobalNASDAQ:ENGTSSOTCMKTS:TSSIView All Competitors VICP Stock Analysis - Frequently Asked Questions How have VICP shares performed in 2024? Vicapsys Life Sciences' stock was trading at $2.74 at the start of the year. Since then, VICP shares have decreased by 83.8% and is now trading at $0.4440. View the best growth stocks for 2024 here. How do I buy shares of Vicapsys Life Sciences? Shares of VICP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:VICP) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersProof that the Musk/Bezos rivalry is about to hit a new levelInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vicapsys Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.